(Q40593421)

English

Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation

scientific article published on October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Wassmann B

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Klein SA

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Scheuring U

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Pfeifer H

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Martin H

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Gschaidmeier H

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hoelzer D

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

721-724

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703222

0 references

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703222

21 January 2018

A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703222

21 January 2018

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703222

21 January 2018

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703222

21 January 2018

Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703222

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703222

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703222

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703222

7 January 2021

based on heuristic

inferred from DOI database lookup

A Bcr/Abl kinase antagonist for chronic myelogenous leukemia: a promising path for progress emerges

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703222

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703222

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40593421&oldid=2085684217"